MBNL1 and myotonic dystrophy type 1: The first small molecule with a demonstrated efficacy in DM1 cell culture models was pentamidine, which was discovered in a large screen for the identification of nucleic acid-binding compounds capable of disrupting the binding of MBNL1 to CUGexp RNA [117].